Leap Therapeutics
LPTX
LPTX
61 hedge funds and large institutions have $14.9M invested in Leap Therapeutics in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
54% less capital invested
Capital invested by funds: $32.7M → $14.9M (-$17.7M)
56% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 18
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
61
Holding in Top 10
–
Calls
$43K
Puts
$4K
Top Buyers
| 1 | +$521K | |
| 2 | +$285K | |
| 3 | +$241K | |
| 4 |
6CM
683 Capital Management
New York
|
+$218K |
| 5 |
BC
BIT Capital
Berlin,
Germany
|
+$145K |
Top Sellers
| 1 | -$2.35M | |
| 2 | -$1.1M | |
| 3 | -$939K | |
| 4 |
TLP
Tri Locum Partners
New York
|
-$626K |
| 5 |
PA
Perceptive Advisors
New York
|
-$336K |